Back to Amundi

AZN

2 quarters

Position history for Amundi's holdings in ASTRAZENECA PLC

Yes. Amundi holds 16,422,784 shares of AZN (AstraZeneca), worth $3.1B, as of its Q2 2026 13F filing. It increased the position by 1,036,635 shares (+6.7%) from Q1 2026. Amundi has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.7% of Amundi's reported 13F portfolio.

Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK